Oh. For. Crying. Out. Loud.
So, they went and did it. The U.S. Centers for Medicare & Medicaid Services (CMS) has extended its temporary moratorium on new Medicare enrollments for hospice and home health agencies (HHAs) for an additional six months.
Originally implemented May 13, 2026, the moratorium suspends initial Medicare enrollment applications from new home health agencies and hospices nationwide. The restrictions also apply to certain changes in majority ownership that require the submission of a new Medicare enrollment application.
CMS continues to use a proverbial sledgehammer rather than a scalpel.
Senior Reporter Holly Vossel and I have written quite a bit on the moratorium on Hospice News, and I have addressed this before on Inside Hospice when I called on CMS to end it. I guess they didn’t hear me – or any of you.
As many stakeholders have pointed out, the restrictions have hindered patient access to care, stifled provider growth, prevented new agencies from opening and disrupted acquisitions and affiliations.
The impact has extended beyond markets with known fraud concerns, leaving some legitimate providers unable to launch operations in areas without widespread reported scams. Some of these are in underserved communities that need greater access to care, particularly rural regions.
However, this extension is a little different that the moratorium’s first round. Now, currently enrolled hospices and home health agencies may add new practice locations under their existing Medicare enrollment, according to CMS.
The modification provides some flexibility for established providers to expand their geographic footprint while the agency continues to restrict new provider enrollment. This could allow some hospices to establish de novos in some markets, depending on the circumstances.
That’s an improvement, and it could ease some of the pressure on providers that has inhibited growth. But even with this modification, I think the moratorium is a mistake. Preventing new entries to the space does not do anything to stop the fraud that is currently occurring.
We’ll report more about this on Hospice News. But for now, I want to try to break down some of the potential impacts:
CMS will continue to restrict new provider enrollments.
Providers will be able to open some de novos if they meet existing requirements, depending on the specific provisions of the CMS extension.
Acquisitions and affiliations will likely continue to see disruption.
Expanding into new markets will be more difficult.
Patient care could be affected by reduced provider availability.
I recently emailed back and forth with CMS officials about the ways they are attacking fraud for a Hospice News story.
“Healthcare fraud is real, documented and devastating — and stealing from people at the most vulnerable moment of their lives isn’t just fraud, it can cost them their future,” CMS Administrator Dr. Mehmet Oz said in an email. “When bad actors trick patients into fraudulent care, they don’t just drain taxpayer dollars; they strip people of medical care that could help them live longer. That’s unconscionable, and CMS is going to drive these predators out of the health system.”
In the course of this reporting, I asked this of CMS: What has the moratorium allowed the agency to do? What kind of work has been happening behind the scenes during these six months?
They really didn’t answer the question, and I would really still like to know. For instance, if they are going to implement an enrollment moratorium, perhaps this would be a good time to improve the way they evaluate and certify enrollment applications?
After all, it bears saying that it was CMS who allowed these fraudulent providers to set up shop in the first place. Perhaps some extenuating circumstances exist, but nevertheless these scammers are Medicare-certified agencies. Improving that process would be a worthy goal. But are they pursuing that?
I really thought that the moratorium might end once the mid-term elections were out of the way. Anti-fraud efforts are popular with voters, and this was a big splashy action that generated headlines. But here we are.
How do you feel about this? Please drop a comment. I am sure we will all be talking about this a lot in the coming months.



CMS already had a narrower tool it could have used. Since 13 July 2023 it has run a provisional period of enhanced oversight for newly enrolling hospices, with medical review including prepayment review, first in Arizona, California, Nevada and Texas, then in Georgia and Ohio from 30 December 2025. Turning to a national moratorium suggests CMS didn't think state-targeted review was working, and it would help if they published that evidence.
This feels like a strategy that can be backed up by the headway made regarding fraud. However, I can’t help but see the advantage this gives to billion dollar entities such as kinderhook. They can easily portray the buy outs that will likely ensue and already have, to be a benefit to HH and hospice as a whole. Without acknowledging the impact it will have on the quality of care and the choices that patients and communities will have when it comes to matter in end of life care